ArticleCancers2020
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma.
Nabanita Mukherjee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papercites it
ArticleCancers2020
Nabanita Mukherjee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.